GFAP and inflammatory bowel disease: We for the first time quantified EGC expressing GFAP and S100β by immunofluorescence and western blotting in the ileum of CD patients and non-IBD controls, and in addition, we distinguished between the distribution in the Peyer’s patches and the surrounding lamina propria.